The results showed that overexpression of PDK4 in the prostatic hyperplasia cell line could suppress the progression of BPH, manifested as a lower level of proliferation, higher level of apoptosis, and limited EMT. This evidence concerns the gene PDK4 and benign prostatic hyperplasia.